Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
NCT03447821
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Infectious Diarrhoea
Interventions
DRUG:
400 mg Rifamycin SV dosage
DRUG:
800 mg Rifamycin SV dosage
DRUG:
1200 mg Rifamycin SV dosage
Sponsor
Cosmo Technologies Ltd